Differential activation of signalling factors following low and high dose of gamma radiation in vivo
by Anirban K. Mitra, Rakesh K. Singh, Himanshi Narang, M. Krishna, Sanjeev K. Maurya
International Journal of Low Radiation (IJLR), Vol. 1, No. 3, 2004

Abstract: The activation of signalling molecules that contribute to the development of radioresistance following radiotherapy was investigated following irradiation with very low doses (0.1 and 0.5 Gy) and high dose (1 and 3 Gy) of γ radiation. Expression of protein kinase C (PKC) was isoform specific. There was a marked difference in the response of ERK 44/42, which is known to confer radioresistance on the tumour cell. The expression at low dose was persistent till 24 hrs with a reappearance at 7 days, while the response at high dose (3 Gy) was transient, an activation at 4 hrs with a return to normal values at the subsequent time periods. These studies indicate that data obtained at high doses should not be extrapolated to low doses. The response of each signalling factor is different at different doses. Since radioadaptation and the development of radioresistance is a low dose phenomenon, ERK 44/42 seems to be the most relevant among the signalling factors.

Online publication date: Fri, 01-Oct-2004

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Low Radiation (IJLR):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com